SCHEMBL7302563

SCHEMBL7302563

CC(C)(C)ONC(=O)C(CSc1ccccc1)Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 2/20 0.47
MMP9 P14780 2/20 0.47
PPARA Q07869 2/20 0.45
CYP1A2 P05177 2/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
ABCC3 O15438 1/20 0.45
NR1I2 O75469 1/20 0.45
ABCB11 O95342 1/20 0.45
NR3C1 P04150 1/20 0.45
RARG P13631 1/20 0.45
CNR1 P21554 1/20 0.45
OPRK1 P41145 1/20 0.45
NR1H2 P55055 1/20 0.45
NR1H3 Q13133 1/20 0.45
NR1I3 Q14994 1/20 0.45
MMP1 P03956 1/20 0.43
FCER2 P06734 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4671067 0.81 MAOA (0.46) CYP1A2CYP3A4CYP2D6CYP2C19EGFR
Hydrochloric Acid SCHEMBL4671065 0.81 MAOA (0.46) CYP1A2CYP3A4CYP2D6CYP2C19EGFR
SCHEMBL7310561 0.79 MMP2 (0.56) MMP2MMP9CYP1A2MMP1FCER2
SCHEMBL23486817 0.76 SLC7A5 (0.54) MMP2ANPEP
SCHEMBL23176795 0.76 CTSS (0.44) ANPEP
SCHEMBL7308337 0.76 MMP9 (0.55) MMP2MMP9PPARAMMP1FCER2
SCHEMBL27463626 0.76 CYP1A2 (0.40) CYP1A2MMEACE
SCHEMBL4673130 0.75 MMP13 (0.49) PPARAMTNR1AMTNR1BPPARGACE
SCHEMBL27463627 0.75 CTSC (0.48) CYP3A4CYP2C19
SCHEMBL4673137 0.75 MMP13 (0.49) PPARAMTNR1AMTNR1BPPARGACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed